Senna and Heavy or prolong menstrual bleeding - a phase IV clinical study of FDA data

Summary:

Heavy or prolong menstrual bleeding is reported as a side effect among people who take Senna (senna), especially for people who are 20-29 old, also take Pegasys, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Heavy or prolong menstrual bleeding when taking Senna. It is created by eHealthMe based on reports of 37,042 people who have side effects when taking Senna from the FDA, and is updated regularly.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 37,302 Senna users. Check the latest studies of Senna.

What is Heavy or prolong menstrual bleeding?

Heavy or prolong menstrual bleeding is found to be associated with 748 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Heavy or prolong menstrual bleeding.

On Jul, 19, 2026

37,042 people reported to have side effects when taking Senna.
Among them, 12 people (0.03%) have Heavy or prolong menstrual bleeding.

Could Senna cause Heavy or prolong menstrual bleeding?

Among these 12 people:

What is the age of people who have Heavy or prolong menstrual bleeding when taking Senna? *

What are other drugs people take besides Senna? *

Chloramphenicol: 8 people, 66.67%
Pegasys: 8 people, 66.67%
Bisacodyl: 7 people, 58.33%
Pregabalin: 7 people, 58.33%
Augmentin: 6 people, 50.00%
Duloxetine Hydrochloride: 5 people, 41.67%
Augmentin '125': 2 people, 16.67%
Tylenol: 2 people, 16.67%
Ondansetron: 2 people, 16.67%
Extraneal: 1 person, 8.33%

What are other side effects people have besides Heavy or prolong menstrual bleeding? *

Gait Disturbance: 9 people, 75.00%
Muscle Spasms (muscle contraction): 9 people, 75.00%
Pain: 9 people, 75.00%
Depressed Mood: 9 people, 75.00%
Depression: 9 people, 75.00%
Drowsiness: 9 people, 75.00%
Fatigue (feeling of tiredness): 9 people, 75.00%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 66.67%
Movement - Uncoordinated: 8 people, 66.67%
Mood Swings (an extreme or rapid change in mood): 8 people, 66.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Neurofibroma (non-cancerous tumours that grow on nerves throughout the body): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 8.33%
Headache (pain in head): 1 person, 8.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Senna and have Heavy or prolong menstrual bleeding?

- Check whether Heavy or prolong menstrual bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Senna:

Senna (37,302 reports)

Browse all side effects of Senna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (748 drugs)

Browse all the conditions that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (1,264 conditions)

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on senna (the active ingredients of Senna) and Senna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.